In the daily primaquine group, one serious adverse event occurred in a G6PD intermediate patient with severe malaria and severe thrombocytopenia requiring transfusion with leucocyte-depleted pooled platelet concentrate for idiopathic thrombocytopenic purpura. The gene discussed is G6PD; the disease is thrombocytopenic purpura.